openPR Logo
Press release

Breast Cancer Therapy Market Is Estimated To Reach US$ 63.13 Billion Growing at CAGR 8.5% By The End Of 2032 | Data by PMR

05-09-2024 11:17 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Breast Cancer Therapy Market

Breast Cancer Therapy Market

๐†๐ฅ๐จ๐›๐š๐ฅ ๐๐ซ๐ž๐š๐ฌ๐ญ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ข๐ณ๐ž ๐š๐ง๐ ๐ฌ๐ก๐š๐ซ๐ž ๐ข๐ฌ ๐œ๐ฎ๐ซ๐ซ๐ž๐ง๐ญ๐ฅ๐ฒ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ‘๐ŸŽ.๐Ÿ—๐ŸŽ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘ ๐š๐ง๐ ๐ข๐ฌ ๐š๐ง๐ญ๐ข๐œ๐ข๐ฉ๐š๐ญ๐ž๐ ๐ญ๐จ ๐ ๐ž๐ง๐ž๐ซ๐š๐ญ๐ž ๐š๐ง ๐ž๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž๐ ๐ซ๐ž๐ฏ๐ž๐ง๐ฎ๐ž ๐จ๐Ÿ ๐”๐’๐ƒ ๐Ÿ”๐Ÿ‘.๐Ÿ๐Ÿ‘ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐š๐œ๐œ๐จ๐ซ๐๐ข๐ง๐  ๐ญ๐จ ๐ญ๐ก๐ž ๐ฅ๐š๐ญ๐ž๐ฌ๐ญ ๐ฌ๐ญ๐ฎ๐๐ฒ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก. ๐๐ž๐ฌ๐ข๐๐ž๐ฌ, ๐ญ๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ง๐จ๐ญ๐ž๐ฌ ๐ญ๐ก๐š๐ญ ๐ญ๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ž๐ฑ๐ก๐ข๐›๐ข๐ญ๐ฌ ๐š ๐ซ๐จ๐›๐ฎ๐ฌ๐ญ ๐Ÿ–.๐Ÿ“% ๐‚๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐ ๐€๐ง๐ง๐ฎ๐š๐ฅ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐‘๐š๐ญ๐ž (๐‚๐€๐†๐‘) ๐จ๐ฏ๐ž๐ซ ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ๐ž๐ ๐ญ๐ข๐ฆ๐ž๐Ÿ๐ซ๐š๐ฆ๐ž, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ - ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ

Growing global cases of breast cancer due to maturing populations, lifestyle alterations, and environmental elements are propelling the market toward growth. Moreover, the technological progressions in treatment alternatives involving aimed therapies, immunotherapy, and accurate medicines are transforming breast cancer management. The cure is customized to distinct patients depending on the biomarkers causing enhanced results and genetic outlines causing enhanced results and decreased side effects.

๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐ก๐ž ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ž๐ซ๐ž:
https://www.polarismarketresearch.com/industry-analysis/breast-cancer-therapy-market/request-for-sample

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ

The global market is excessively competitive because of the existence of an extensive number of players. Key companies in the breast cancer therapy market are mentioned below:

โ€ข Novartis AG
โ€ข Pfizer Inc.
โ€ข Merck KGaA
โ€ข Janssen Pharmaceuticals, Inc.
โ€ข Celgene Corporation, Inc.
โ€ข Genzyme Corp.
โ€ข F. Hoffmann-La Roche Ltd.
โ€ข AstraZeneca
โ€ข AbbVie Inc.
โ€ข Bristol-Myers Squibb Company
โ€ข Macrogenics, Inc.
โ€ข Celldex Therapeutics
โ€ข Onyx Pharmaceuticals Inc.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ญ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง

Breast cancer is a kind of cancer that commences in the breast, and it can commence in one or both breasts. Cancer commences when cells go out of control. The breast is a body part that perches on the upper ribs and chest muscles. There is a left and right breast, and every person has predominantly glands, ducts, and fatty tissues.

In women, the breast renders milk to cater to newborns and infants. The quantity of fatty tissue in the breast decides the size of each breast. Breast cancer can develop when the cancer cells familiarise themselves with the blood or lymph systems and are hauled to alternate parts of the body.

๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐“๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/314/2

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐’๐œ๐จ๐ฉ๐ž

The countries covered in the market report are Europe, North America, Latin America, Asia Pacific, and the Middle East & Africa. According to the analysis, in 2023, North America dominated the market with the largest share. The region is encountering elevated cases of breast cancer, generating a robust demand for productive cure alternatives. It brags of an entrenched healthcare framework and invasion of progressive medical techniques, which are some of the key drivers of the market's expansion in North America. Moreover, with a strong CAGR throughout the foreseen period, the Asia Pacific region is expected to expand at the quickest rate.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค

๐๐ฒ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ

โ€ข Chemotherapy
โ€ข Hormonal Therapy
โ€ข Aromatase Inhibitors
โ€ข Estrogen Receptor Down regulators (ERDs)
โ€ข Selective Estrogen Receptor Modulators (SERMs)
โ€ข Targeted Therapy
โ€ข Ribociclib
โ€ข Palbociclib
โ€ข Pertuzumab

๐๐ฒ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ฒ๐ฉ๐ž
โ€ข Hormone Receptor
โ€ข HER2+
โ€ข Others

๐๐ฒ ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ
โ€ข Retail Pharmacies
โ€ข Hospital Pharmacies
โ€ข Others

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐Œ๐จ๐ซ๐ž ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ฌ:
https://www.polarismarketresearch.com/industry-analysis/breast-cancer-therapy-market

๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ:

โ€ข๐ˆ๐ง๐œ๐ซ๐ž๐š๐ฌ๐ข๐ง๐  ๐ˆ๐ง๐œ๐ข๐๐ž๐ง๐œ๐ž: The rising incidence of breast cancer globally is a significant driver of market growth. Factors such as aging populations, lifestyle changes, genetic predisposition, and environmental factors contribute to the increasing burden of breast cancer.

โ€ข ๐€๐๐ฏ๐š๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ ๐ข๐ง ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ: Ongoing research and development efforts have led to the discovery of novel therapeutic agents and treatment strategies, driving innovation in breast cancer therapy. Targeted therapies, immunotherapies, and personalized medicine approaches offer new avenues for improving treatment outcomes and patient survival rates.

โ€ข๐„๐š๐ซ๐ฅ๐ฒ ๐ƒ๐ž๐ญ๐ž๐œ๐ญ๐ข๐จ๐ง ๐š๐ง๐ ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ข๐ฌ: Advances in breast cancer screening, imaging technologies, and biomarker testing enable early detection and diagnosis of breast cancer, leading to timely initiation of treatment and better prognosis. Early-stage detection increases the likelihood of successful treatment and improves patient outcomes.

โ€ข ๐ˆ๐ฆ๐ฉ๐ซ๐จ๐ฏ๐ž๐ ๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐จ ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž: Efforts to improve access to healthcare services, including breast cancer screening programs, diagnostic facilities, and treatment centers, contribute to the early detection and management of breast cancer, driving demand for therapeutic interventions.

๐๐ซ๐ž๐š๐ฌ๐ญ ๐‚๐š๐ง๐œ๐ž๐ซ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ

โ€ข The targeted therapy design segment dominated the market in 2023, driven by significant transformation with the introduction of targeted medicines, such as novel medications that target other cellular pathways involved in the growth and survival of breast cancer are also showing promise in clinical studies.

โ€ข The hormone receptor segment led the market in 2023 and is expected to maintain its dominance due to the rising incidence of breast cancer.

โ€ข North America holds a significant revenue share in the global breast cancer therapy market, driven by the region experiences high incidence of breast cancer, creating a strong demand for effective treatment options.

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐€ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ:
https://www.polarismarketresearch.com/industry-analysis/hemophilia-a-treatment-market

๐Ÿ‘๐ƒ ๐‚๐ž๐ฅ๐ฅ ๐‚๐ฎ๐ฅ๐ญ๐ฎ๐ซ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/3d-cell-culture-market

๐‚๐š๐ง๐œ๐ž๐ซ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/cancer-immunotherapy-market

๐•๐š๐œ๐œ๐ข๐ง๐ž ๐€๐๐ฃ๐ฎ๐ฏ๐š๐ง๐ญ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/vaccine-adjuvants-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Breast Cancer Therapy Market Is Estimated To Reach US$ 63.13 Billion Growing at CAGR 8.5% By The End Of 2032 | Data by PMR here

News-ID: 3490609 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โ€ฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโ€ฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โ€ฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected toโ€ฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โ€ฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโ€ฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โ€ฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโ€ฆ

All 5 Releases


More Releases for Breast

Breast Health Monitoring App Market to Witness a Pronounce Growth during 2024-20 โ€ฆ
The latest market intelligence report published by WMR with the title "Global Breast Health Monitoring App Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Healthcare and Pharmaceuticals industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database. The Research report on Breast Health Monitoring App Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Yโ€ฆ
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer โ€ฆ
FOR IMMEDIATE RELEASE Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer During Breast Cancer Awareness Month Liverpool, UK - October, 2023 - Phil Alderson, a primary survivor of male breast cancer, is taking bold steps this Breast Cancer Awareness Month to raise awareness of this often overlooked aspect of the disease. With a homemade cardboard sign that reads "Check Your Pecks," Phil has taken to the streets ofโ€ฆ
Breast Health Monitoring App Market Recent Trends, In-depth Analysis, Size, and โ€ฆ
According to The Worldwide Market Reports, the Latest research report on "Breast Health Monitoring App Market Size, Revenue, Global Analysis, and Forecast 2023 to 2030" The Breast Health Monitoring App Market research study is a professional report with premium insights into the size of the business, current patterns, drivers, risks, potential outcomes, and major segments. The Industry Report forecasts the future growth of the market based on precise assumptions. Furthermore,โ€ฆ
Breast Pumps Market - Nurturing Convenience: Revolutionizing Breast Pump Technol โ€ฆ
Newark, New Castle, USA - new report, titled Breast Pumps Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Breast Pumps market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Breast Pumps market. The report offers an overview of the market, whichโ€ฆ
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U โ€ฆ
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues. Download Free PDF Brochure on Brest Imaging Market Report Nowโ€ฆ
Breast Implants Market Report 2018: Segmentation by Product (Silicone Breast Imp โ€ฆ
Global Breast Implants market research report provides company profile for Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 toโ€ฆ